When did Capricor Therapeutics report Q4 2024 earnings?

Capricor Therapeutics (CAPR) reported Q4 2024 earnings on March 19, 2025 after market close.

What were Capricor Therapeutics's Q4 2024 revenue and EPS?

Capricor Therapeutics reported revenue of $11.1M and diluted EPS of $-0.16 for Q4 2024.

Did Capricor Therapeutics beat estimates in Q4 2024?

Revenue beat the consensus estimate of $5.5M by $5.6M. EPS beat the consensus estimate of $-0.31 by $0.15.

Where can I find Capricor Therapeutics's Q4 2024 SEC filings?

You can read the 10-K periodic report (0001558370-25-003707) directly on SEC EDGAR. The filing index links above go to sec.gov.

Capricor Therapeutics CAPR Q4 2024 Annual earnings

Reported March 19, 2025 · After market close

Revenue$11.1MBeat by $5.6M Diluted EPS-$0.16Beat by $0.15

Revenue estimate$5.5M

EPS estimate-$0.31

Next report

Aug 11, 2026 (In 4 weeks)

Revenue estimate$2.1M

EPS estimate-$0.58

Financials

Q4 2024

Income statement

See full

Revenue$11.1M-7.9%

Operating income-$7.7M-501%

Net income-$7.1M-834%

EPS (diluted)-$0.11—

Balance sheet

See full

Cash & equivalents$11.3M-23.2%

Total debt$1.5M-74.1%

Total equity$145.5M+544%

Total assets$170.5M+190%

Cash flow

See full

Operating cash flow-$14.8M-27.6%

CapEx$488.8K-12.5%

Free cash flow-$15.3M-25.8%

Valuation & ratios

Valuation

as of 12/31/24

See full

Market cap$627.48M+317%

Enterprise value$617.65M+337%

P/S28.2×+22.2×

Profitability

See full

Operating margin-191.1%+129,524pp

Net margin-181.7%-3,627pp

FCF margin-184.8%+498pp

Returns & leverage

See full

Return on equity-48.2%-18.6pp

Debt / equity0×-0.2×

Current ratio7.8×+6.1×

Versus estimates

Revenue

Q4 2024$11.1MBeat by $5.6M

Diluted EPS

Q1 2026-$0.59Miss by $0.04 Q4 2025-$0.62Miss by $0.11 Q3 2025-$0.54In line Q2 2025-$0.57Miss by $0.09 Q1 2025-$0.53Miss by $0.20

Q4 2024-$0.16Beat by $0.15

Ask the moment Capricor Therapeutics reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Capricor Therapeutics report Q4 2024 earnings?: Capricor Therapeutics (CAPR) reported Q4 2024 earnings on March 19, 2025 after market close.
What were Capricor Therapeutics's Q4 2024 revenue and EPS?: Capricor Therapeutics reported revenue of $11.1M and diluted EPS of $-0.16 for Q4 2024.
Did Capricor Therapeutics beat estimates in Q4 2024?: Revenue beat the consensus estimate of $5.5M by $5.6M. EPS beat the consensus estimate of $-0.31 by $0.15.
Where can I find Capricor Therapeutics's Q4 2024 SEC filings?: You can read the 10-K periodic report (0001558370-25-003707) directly on SEC EDGAR. The filing index links above go to sec.gov.